Morgan Stanley’s Imperva, Inc. IMPV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-117,905
Closed -$6.57M 6897
2018
Q4
$6.57M Sell
117,905
-422
-0.4% -$22.9K ﹤0.01% 2569
2018
Q3
$5.5M Sell
118,327
-205,807
-63% -$9.96M ﹤0.01% 3084
2018
Q2
$15.6M Buy
324,134
+35,424
+12% +$1.69M ﹤0.01% 1883
2018
Q1
$12.5M Buy
288,710
+22,709
+9% +$1.02M ﹤0.01% 2121
2017
Q4
$10.6M Buy
266,001
+25,051
+10% +$1.04M ﹤0.01% 2340
2017
Q3
$10.5M Sell
240,950
-163,161
-40% -$7.45M ﹤0.01% 2225
2017
Q2
$19.3M Buy
404,111
+183,819
+83% +$8.57M 0.01% 1560
2017
Q1
$9.04M Buy
220,292
+101,772
+86% +$4.25M ﹤0.01% 2299
2016
Q4
$4.55M Buy
118,520
+73,141
+161% +$2.97M ﹤0.01% 3098
2016
Q3
$2.44M Sell
45,379
-24,530
-35% -$1.14M ﹤0.01% 3325
2016
Q2
$3.01M Buy
69,909
+44,399
+174% +$1.86M ﹤0.01% 3078
2016
Q1
$1.29M Sell
25,510
-118,796
-82% -$5.71M ﹤0.01% 3717
2015
Q4
$9.14M Buy
144,306
+121,796
+541% +$8.29M ﹤0.01% 2067
2015
Q3
$1.47M Buy
22,510
+13,892
+161% +$922K ﹤0.01% 3781
2015
Q2
$583K Sell
8,618
-7,570
-47% -$418K ﹤0.01% 4610
2015
Q1
$691K Buy
16,188
+9,517
+143% +$423K ﹤0.01% 4408
2014
Q4
$329K Sell
6,671
-22,954
-77% -$919K ﹤0.01% 4950
2014
Q3
$852K Buy
29,625
+7,569
+34% +$206K ﹤0.01% 4179
2014
Q2
$578K Buy
22,056
+19,185
+668% +$495K ﹤0.01% 4473
2014
Q1
$160K Sell
2,871
-2,997
-51% -$172K ﹤0.01% 5218
2013
Q4
$283K Sell
5,868
-45,917
-89% -$1.93M ﹤0.01% 4846
2013
Q3
$2.17M Buy
51,785
+46,547
+889% +$2.22M ﹤0.01% 3146
2013
Q2
$236K Buy
+5,238
New +$205K ﹤0.01% 4745

Morgan Stanley's IMPV Position: Q1 2019 in Review

Morgan Stanley sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 117,905 shares — an estimated $6.57M sold.

Morgan Stanley first reported a position in IMPV in Q2 2013 and held it in 23 quarters. The position peaked at $19.3M in Q2 2017. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.

  • Morgan Stanley reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
  • Morgan Stanley sold 117,905 Imperva, Inc. shares in Q1 2019, an estimated $6.57M.
  • Morgan Stanley first reported a position in Imperva, Inc. in Q2 2013 and held it in 23 quarters.
  • Morgan Stanley's Imperva, Inc. position peaked at $19.3M in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.

Based on Morgan Stanley's 13F filing for Q1 2019, filed 15 May 2019.